The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma

Published:2012-10 Issue:9 Volume:36 Page:515-520
ISSN:2173-5786
Container-title:Actas Urológicas Españolas (English Edition)
language:en
Short-container-title:Actas Urológicas Españolas (English Edition)

Author:

Gunlusoy B.,Arslan M.,Vardar E.,Degirmenci T.,Kara C.,Ceylan Y.,Kozacıoğlu Z.

Publisher

Elsevier BV

Reference27 articles.

1. Cancer of the bladder;Herr,2001

2. Long term follow up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Saxman;J Clin Oncol,1997

3. Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer;Vogelzang;Urology,1999

4. Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy;Nogue-Aliquer;Cancer,2003

5. Systemic chemotherapy in locally advanced metastatic bladder cancer;Pectasides;Cancer Treat Rev,2006

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report;Frontiers in Oncology;2021-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP